Antigen Peptide EBV LMP2 HLA-A*0201 (FLYALALLL) 10 mg

EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

US$533.00

Excluding tax and shipping fees

In stock

Description

About EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

The Epstein-Barr Virus (EBV) Latent membrane protein 2 (LMP2) Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Latent membrane protein 2 (LMP2) Peptide, H-FLYALALLL-OH (Uniprot: P13285 aa: 356-364) from JPT is produced under strict quality control and quality management.

EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL - Specifications

Peptide sequence: H-FLYALALLL-OH

Amount: 10 mg (10 x 1 mg)

Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)

Delivery Format: Freeze-dried in plastic vial

Application(s): T-cell immunity

Condition(s)/Topic(s): Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma, Infectious mononucleosis

Standard Delivery Time: approx. 10 days

Visit our webpage for more information on Peptide Tools to Study EBV

Your Custom or Scrambled Antigen Peptide!

Do you need a scrambled version of this antigen peptide?We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!

Are you interested in other antigen peptides?Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

JPT’s Antigen PeptidesFind your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides- All peptides are made in Germany- Bulk orders or custom peptide snythesis upon request- Synthesis protocols designed to avoid toxic contaminants and side products - Provision of freeze dried aliquots for enhanced stability - Proven track record for applications in clinical studies- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

References:Read References with Antigen Peptides

Documentation

Documentation for EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

Protocol_PepMix.pdf

EBV-LMP2-356-364-Peptide-FLYALALLL-3.pdf

Properties

Properties of EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

T-cell immunity

Antigen Peptides

Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma

Freeze-dried in plastic vial

Epstein-Barr Virus (EBV)

Latent membrane protein 2 (LMP2)

Trial Grade: each peptide purified to > 90% (HPLC/MS)

No

Further Information to EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

Values

H-FLYALALLL-OH

9mer peptide as TFA salt